权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Clinical Impact of Unstable AED Levels in Elderly Nursing Home Epilepsy Patients

不稳定的 AED 水平对老年疗养院癫痫患者的临床影响

基本信息

批准号：
8130874
负责人：
ANGELA K BIRNBAUM
金额：
$ 38.77万
依托单位：
UNIVERSITY OF MINNESOTA
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-09-01 至 2013-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8130874
关键词：
Accident and Emergency department Activities of Daily Living Adverse effects Adverse event Antidepressive Agents Antiepileptic Agents Ataxia Beds Blood CYP2C19 gene CYP2C9 gene Calcium Channel Blockers Censuses Clinical Clinical Management Cognition Concentration measurement Cytochrome P450 Data Direct Costs Discipline of Nursing Dose Drug Costs Drug Formulations Drug Kinetics Drug usage Elderly Enrollment Enzymes Epilepsy Exhibits Foundations Fracture Frequencies Gene Mutation Geriatric Assessment Goals Hospitalization Individual Kidney Kinetics Lead Levetiracetam Long-Term Care Measures Metabolic Metabolism Monitor New York Nursing Homes Outcome Outcome Measure Pathologic Nystagmus Patients Persons Pharmaceutical Preparations Pharmacotherapy Phenytoin Population Quality of life Recruitment Activity Reporting Research Personnel Seizures Serum Site Techniques Testing Therapeutic Time Toxic effect United States Variant Visit Water adverse outcome alertness cost cost effectiveness cost utility analysis evidence based guidelines experience falls health related quality of life innovation instrument lamotrigine national surveillance novel pharmacokinetic characteristic programs prospective response surveillance study young adult

项目摘要

DESCRIPTION (provided by applicant): Although phenytoin (PHT) has been attributed to falls in the elderly and is very difficult to dose due to complicated pharmacokinetics, it continues to be the most frequently prescribed antiepileptic drug (AED) in nursing homes with 6% of the approximately 1.5 million residents in the United States receiving it. PHT is a difficult AED to dose for optimal therapeutic outcome because its elimination kinetics are nonlinear, its concentrations within a patient can be extremely variable (unstable), and it alters the metabolism of many other medications used in this population. Newer AEDs such as lamotrigine (LTG) and levetiracetam (LEV) appear to have more desirable pharmacokinetic characteristics and their use may lead to better outcomes than use of PHT. However, there is no information regarding the outcomes of AED use in nursing homes, the proper use of AED concentrations to guide management, and the cost-effectiveness of using older AEDs versus newer more expensive ones. Our group discovered that PHT concentrations fluctuate markedly within many nursing home patients even when there is no change in dose and no change in co-medications. The fluctuations in 64.3% of these patients were greater than 5 ug/ml, a change that has been reported to increase seizure activity in other populations. In addition, many patients had PHT concentrations above those that have been associated with adverse events. This study will be the first to collect prospective outcome information (seizures and adverse events) at the time of a blood draw in elderly nursing home residents treated with PHT, LTG, and LEV. Results will help define the appropriate levels of these AEDs for optimal outcomes, identify factors associated with instability of PHT levels, determine if the newer AEDs are associated with fewer adverse events, evaluate the usefulness of measuring AEDs, and determine the total costs (drug, hospitalizations, nursing time, etc.) of AED therapy in the nursing home setting. We have recruited four major nursing home sites in two geographical regions (Minneapolis and New York) with a combined bed census of over 7,000 residents. We will enroll 200 nursing home residents on AED therapy to attain a study group of 175 subjects (50 LEV, 50 LTG, 75 PHT). They will be studied five times over approximately a 9-month period. The long-term goal of this project is to provide the foundation for creating the first evidence-based recommendations for the use of AEDs for nursing home residents.

描述（申请人提供）：尽管苯妥英（PHT）已被归因于老年人的福尔斯跌倒，并且由于复杂的药代动力学而非常难以给药，它仍然是疗养院最常用的抗癫痫药物（AED），PHT是一种难以剂量的AED以获得最佳治疗结果，因为其消除动力学是非线性的，其在患者体内的浓度可以是极其可变的（不稳定的），并且其改变了在该群体中使用的许多其它药物的代谢。较新的AED如拉莫三嗪（LTG）和左乙拉西坦（LEV）似乎具有更理想的药代动力学特征，使用它们可能比使用PHT产生更好的结局。然而，目前还没有关于在养老院使用AED的结果，正确使用AED浓度来指导管理，以及使用旧AED与更新更昂贵的AED的成本效益的信息。我们的研究小组发现，即使在剂量和合并用药没有变化的情况下，许多疗养院患者体内的PHT浓度也有明显的波动。这些患者中有64.3%的波动大于5 μ g/ml，据报道，这种变化会增加其他人群的癫痫发作活动。此外，许多患者的PHT浓度高于与不良事件相关的浓度。这项研究将是第一个收集前瞻性的结果信息（癫痫发作和不良事件）时，抽血的老年疗养院居民治疗PHT，LTG，LEV。结果将有助于确定这些AED的适当水平以获得最佳结果，确定与PHT水平不稳定相关的因素，确定较新的AED是否与较少的不良事件相关，评估测量AED的有用性，并确定总成本（药物，住院，护理时间等）。在疗养院环境中的AED治疗。我们在两个地理区域（明尼阿波利斯和纽约）招募了四个主要的养老院站点，并对7,000多名居民进行了合并床位普查。我们将招募200名接受AED治疗的疗养院居民，以获得175名受试者（50名LEV，50名LTG，75名PHT）的研究组。他们将在大约9个月的时间内进行五次研究。该项目的长期目标是为创建养老院居民使用AED的第一个循证建议提供基础。